Sarepta Therapeutics
SRPT
#5101
Rank
โ‚น185.27 B
Marketcap
โ‚น1,754
Share price
0.88%
Change (1 day)
6.69%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2026 (TTM): โ‚น3.02 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are โ‚น2.18 Billion. In 2025 the company made an earning of -โ‚น67.02 Billion a decrease over its 2024 earnings that were of โ‚น24.88 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น3.02 B-104.52%
2025 -โ‚น67.02 Billion-369.28%
2024 โ‚น24.88 B-150.14%
2023 -โ‚น49.64 Billion-24.62%
2022 -โ‚น65.85 Billion64.69%
2021 -โ‚น39.99 Billion-24.25%
2020 -โ‚น52.78 Billion-22.53%
2019 -โ‚น68.13 Billion96.87%
2018 -โ‚น34.61 Billion645.68%
2017 -โ‚น4.65 Billion-81.81%
2016 -โ‚น25.51 Billion21.47%
2015 -โ‚น21 Billion62.04%
2014 -โ‚น12.96 Billion21.26%
2013 -โ‚น10.69 Billion60.93%
2012 -โ‚น6.65 Billion93.69%
2011 -โ‚น3.43 Billion71.58%
2010 -โ‚น2 Billion35.06%
2009 -โ‚น1.48 Billion-11.62%
2008 -โ‚น1.68 Billion-47.02%
2007 -โ‚น3.16 Billion0.38%
2006 -โ‚น3.15 Billion88.3%
2005 -โ‚น1.68 Billion-30.06%
2004 -โ‚น2.39 Billion32.69%
2003 -โ‚น1.81 Billion-25.52%
2002 -โ‚น2.42 Billion64.52%
2001 -โ‚น1.47 Billion50.4%
2000 -โ‚น0.98 Billion26.44%
1999 -โ‚น0.78 Billion8%
1998 -โ‚น0.72 Billion102.7%
1997 -โ‚น0.36 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น1.023 T 43,746.81%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น22.5 Billion-1,063.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น6.16 Billion-363.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น82.99 B 3,454.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น105.13 Billion-4,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น43.35 Billion-1,956.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น65.34 Billion-2,898.18%๐Ÿ‡บ๐Ÿ‡ธ USA